Issues in noninferiority trials: the evidence in community-acquired pneumonia (Q37170063)

18 August 2017

1 reference

title

Issues in noninferiority trials: the evidence in community-acquired pneumonia (English)

1 reference

18 August 2017

0 references

Thomas R Fleming

1

1 reference

PMCID

2673530

18 August 2017

John H Powers

series ordinal

2

1 reference

PMCID

2673530

18 August 2017

language of work or name

English

0 references

publication date

1 December 2008

1 reference

Clinical Infectious Diseases

18 August 2017

1 reference

18 August 2017

47 Suppl 3

1 reference

18 August 2017

S108-20

1 reference

Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2673530

Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2673530

Empirical atypical coverage for inpatients with community-acquired pneumonia: systematic review of randomized controlled trials

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2673530

Effectiveness of beta lactam antibiotics compared with antibiotics active against atypical pathogens in non-severe community acquired pneumonia: meta-analysis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2673530

Outcomes in lower respiratory tract infections and the impact of antimicrobial drug resistance

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2673530

The community-acquired pneumonia symptom questionnaire: a new, patient-based outcome measure to evaluate symptoms in patients with community-acquired pneumonia

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2673530

6 September 2017

Noninferiority trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2673530

A prediction rule to identify low-risk patients with community-acquired pneumonia

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2673530

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2673530

THE TREATMENT OF PNEUMOCOCCIC PNEUMONIA WITH SULFAPYRIDINE

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2673530

THE TREATMENT OF PNEUMOCOCCAL PNEUMONIA WITH DAGENAN (M. & B. 693).

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2673530

Surrogate end points in clinical trials: are we being misled?

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2673530

Results of the Treatment of 400 Cases of Lobar Pneumonia with M & B 693: (Section of Medicine).

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2673530

Reassessing the design, conduct, and analysis of clinical trials of therapy for community-acquired pneumonia

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2673530

Combined endpoints: can we use them?

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2673530

Randomized versus historical controls for clinical trials.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2673530

Surrogate Endpoints And FDA’s Accelerated Approval Process

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2673530

The effect of antibiotics (penicillin, aureomycin, and terramycin) on the fatality rate and incidence of complications in pneumococcic pneumonia; a comparison with other methods of therapy

4 December 2018

1 reference

12 December 2020

Bacteremic and nonbacteremic pneumococcal pneumonia. A prospective study

1 reference

12 December 2020

Success rates for new drugs entering clinical testing in the United States

1 reference

12 December 2020

Community acquired pneumonia

1 reference

12 December 2020

Increasing the efficiency of clinical trials of antimicrobials: the scientific basis of substantial evidence of effectiveness of drugs

1 reference

12 December 2020

Noninferiority and equivalence trials: deciphering 'similarity' of medical interventions

1 reference

12 December 2020

Non-inferiority trials are unethical because they disregard patients' interests

1 reference

12 December 2020

PNEUMOCOCCAL BACTEREMIA WITH ESPECIAL REFERENCE TO BACTEREMIC PNEUMOCOCCAL PNEUMONIA

1 reference

12 December 2020

Current issues in non-inferiority trials

1 reference

12 December 2020

Identifiers

DOI

10.1086/591390

1 reference

18 August 2017

1 reference

18 August 2017

1 reference

PMCID

2673530